Soleus Capital Management, L.P. Karuna Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

  • $1.22 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$164.66 - $218.08 $1.27 Million - $1.68 Million
-7,700 Reduced 54.46%
6,440 $1.09 Million
Q2 2023

Aug 14, 2023
SELL
$176.32 - $240.22 $3.46 Million - $4.71 Million
-19,600 Reduced 58.09%
14,140 $3.07 Million
Q1 2023

May 15, 2023
BUY
$161.33 - $204.36 $5.44 Million - $6.9 Million
33,740 New
33,740 $6.13 Million

Others Institutions Holding KRTX

# of Institutions
13
Shares Held
333K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email